Champions Oncology (CSBR) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.08 -0.39%
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
ANAB, ANIX, MNY, More
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q4 EPS of $0.01, $0.06 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $12.89 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Colgate-Palmolive explores sale of Softsoap, Irish Spring brands
- QatarEnergy trading seeks 2-3M tons per annum of LNG through 2031 as Ras Laffan repairs are seen raking 3-5 years - Reuters
- Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
